Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan · Delayed Price · Currency is TWD 20.95
+0.25 (1.21%)
Oct 30, 2026, 1:29 PM CST
Diamond Biotechnology Market Cap
Diamond Biotechnology has a market cap or net worth of 831.82 million as of October 30, 2026. It is the 34,955th most valuable company in the world and the 2,107th biggest in Taiwan. Its market cap has decreased by 69.80% in one year.
Market Cap
831.82M
Enterprise Value
789.97M
Revenue
464.63M
Global Rank
Country Rank
#2,107 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since January 29, 2021, Diamond Biotechnology's market cap has decreased from 1.68B to 831.82M, a decrease of -50.51%. That is a compound annual growth rate of -11.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 831.82M | -66.78% |
| Dec 31, 2025 | 2.50B | -7.50% |
| Dec 31, 2024 | 2.71B | 12.05% |
| Dec 29, 2023 | 2.42B | 179.34% |
| Dec 30, 2022 | 864.86M | -11.33% |
| Dec 30, 2021 | 975.37M | -41.97% |
| Jan 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AViTA | 1.38B |
| NaviFUS | 1.37B |
| Bioptik Technology Incorporation | 1.29B |
| AmCad BioMed | 1.12B |
| S&S Healthcare Holding | 1.10B |
| Rossmax International | 1.06B |
| Wiltrom | 940.41M |
| Cowealth Medical Holding | 784.72M |